TempraMed Technologies Ltd. engages in the providing innovative, temperature-controlled medication storage solutions. It develops patented, FDA-registered, space-grade thermal insulation hassle-free devices that work for years without charging or external power. The company enables patients and healthcare providers to confidently manage temperature-sensitive medications anywhere using its product line including VIVICap and VIVIEpi. TempraMed Technologies was founded on December 31, 2023 and is headquartered in Vancouver, Canada.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for TempraMed Technologies Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. TempraMed Technologies Ltd. 52 week high is $0.45 as of May 30, 2026.
What is the 52-week low for TempraMed Technologies Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. TempraMed Technologies Ltd. 52 week low is $0.40 as of May 30, 2026.
What is TempraMed Technologies Ltd. stock price today?
TempraMed Technologies Ltd. stock price today is $0.45.
What is the 50-day moving average of TempraMed Technologies Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. TempraMed Technologies Ltd. 50-day moving average is $0.45.